These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35713866)

  • 1. A Hybrid Protocol for Identifying Comorbidity-Based Potential Drugs for COVID-19 Using Biomedical Literature Mining, Network Analysis, and Deep Learning.
    Prabahar A; Palanisamy A
    Methods Mol Biol; 2022; 2496():203-219. PubMed ID: 35713866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review.
    Albahri AS; Hamid RA; Alwan JK; Al-Qays ZT; Zaidan AA; Zaidan BB; Albahri AOS; AlAmoodi AH; Khlaf JM; Almahdi EM; Thabet E; Hadi SM; Mohammed KI; Alsalem MA; Al-Obaidi JR; Madhloom HT
    J Med Syst; 2020 May; 44(7):122. PubMed ID: 32451808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
    Ting CT; Chen BS
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
    Das AB
    BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review on Screening Models for Potential Therapeutic Candidates and Targets Against SARS-CoV-2.
    Das M; Kumar M; Jha A; Madhukiran DR; Bharti K; Mondal S; Mishra B
    Curr Drug Targets; 2021; 22(11):1232-1254. PubMed ID: 33371846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB.
    Rico-Mesa JS; White A; Anderson AS
    Curr Cardiol Rep; 2020 Apr; 22(5):31. PubMed ID: 32291526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].
    Javelot H; Llorca PM; Drapier D; Fakra E; Hingray C; Meyer G; Dizet S; Egron A; Straczek C; Roser M; Masson M; Gaillard R; Fossati P; Haffen E
    Encephale; 2020 Jun; 46(3S):S14-S34. PubMed ID: 32376004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods.
    Kivrak M; Guldogan E; Colak C
    Comput Methods Programs Biomed; 2021 Apr; 201():105951. PubMed ID: 33513487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2.
    Su X; Hu L; You Z; Hu P; Wang L; Zhao B
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34965582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review.
    Deravi N; Fathi M; Vakili K; Yaghoobpoor S; Pirzadeh M; Mokhtari M; Fazel T; Ahsan E; Ghaffari S
    Rev Cardiovasc Med; 2020 Sep; 21(3):385-397. PubMed ID: 33070543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight.
    Akilesh SM; J R; Palanisamy D; Wadhwani A
    Curr Pharm Biotechnol; 2021; 22(2):192-199. PubMed ID: 32867651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19: Between Past and Present.
    Assaf AM; Haddadin RN; Akour AA
    Viral Immunol; 2021 Apr; 34(3):145-157. PubMed ID: 33017280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep Learning in the Quest for Compound Nomination for Fighting COVID-19.
    Mernea M; Martin EC; Petrescu AJ; Avram S
    Curr Med Chem; 2021; 28(28):5699-5732. PubMed ID: 33441063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature.
    Ukwenya VO; Adelakun SA; Fuwape TA; Adeagbo AS
    Curr Diabetes Rev; 2022; 18(3):e060821195355. PubMed ID: 34365925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent omics-based computational methods for COVID-19 drug discovery and repurposing.
    Tayara H; Abdelbaky I; To Chong K
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34423353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study.
    Kosiborod M; Berwanger O; Koch GG; Martinez F; Mukhtar O; Verma S; Chopra V; Javaheri A; Ambery P; Gasparyan SB; Buenconsejo J; Sjöström CD; Langkilde AM; Oscarsson J; Esterline R
    Diabetes Obes Metab; 2021 Apr; 23(4):886-896. PubMed ID: 33319454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
    Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
    Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.